EXR
40
-6
CTSH
42
-3
CHD
51
-2
AA
50
-3
CVS
56
-2
SPG
43
-2
IFF
38
-4
AON
73
-2
VLO
45
-3
JNJ
56
5
MSFT
53
3
AVY
51
-2
MS
53
-9
MHK
37
-5
UNH
52
3
R
61
2
VRSK
59
-2
ETR
63
-2
RIG
25
-3
DOV
57
-3
EXR
40
-6
CTSH
42
-3
CHD
51
-2
AA
50
-3
CVS
56
-2
SPG
43
-2
IFF
38
-4
AON
73
-2
VLO
45
-3
JNJ
56
5
MSFT
53
3
AVY
51
-2
MS
53
-9
MHK
37
-5
UNH
52
3
R
61
2
VRSK
59
-2
ETR
63
-2
RIG
25
-3
DOV
57
-3
Financhill
Back

Seritage Growth Properties Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
5

SRG
Seritage Growth Properties

Last Price:
$3.28
Seasonality Move:
-1.12%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$74.08
Seasonality Move:
14.66%
Sell
5
Seritage Growth Properties (SRG) is a Sell

Is Seritage Growth Properties a Buy, Sell or Hold?

  • The current Seritage Growth Properties [SRG] share price is $3.27. The Score for SRG is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • SRG is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRG Stock Price Chart

What is Seritage Growth Properties's stock price today?

  • The Seritage Growth Properties share price today is $3.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRG is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $74.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

SRG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 37.78 Sell
Chaikin Money Flow: -168579 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.35 - 3.75) Sell
Bollinger Bands (100): (3.62 - 4.32) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.7 Sell
Relative Strength Index (14 RSI): 27.9 Sell
Chaikin Money Flow: -367389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.59 - 111.17) Sell
Bollinger Bands (100): (103.29 - 127.87) Sell

SRG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.4 Sell
20-day SMA: 3.52 Sell
50-day SMA: 3.68 Sell
200-day SMA: 4.33 Sell
8-day EMA: 3.41 Sell
20-day EMA: 3.49 Sell
50-day EMA: 3.68 Sell
200-day EMA: 4.72 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.22 Sell
20-day SMA: 97.87 Sell
50-day SMA: 108.64 Sell
200-day SMA: 125.16 Sell
8-day EMA: 84.58 Sell
20-day EMA: 94.74 Sell
50-day EMA: 105.16 Sell
200-day EMA: 118.38 Sell

Seritage Growth Properties Earnings Growth & SRG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Seritage Growth Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):